Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 149 | Longs Won 83/146 56% | Profit Factor 1.43 |
| Profitability | Shorts Won 2/3 66% | Standard Deviation $7,894.52 |
| Average Win $4,242.97 | Best Trade (Mar 08) $45,981.74 | Sharpe Ratio -48.55 |
| Average Loss -$3,943.43 | Worst Trade (Jan 16) -$32,554.16 | Z-Score -3.44 (100%) |
| Commissions $0 | Avg. Trade Length 1m 4w 1d | Expectancy $747.19 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | 0.03% | 0.25% | 1.05% | 3.18% | 7.89% | 16.97% | 32.97% | 59.22% |
| Consecutive Losing Trades | 54 | 48 | 43 | 38 | 32 | 27 | 21 | 16 | 11 | 5 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
BBIO BridgeBio Pharma, Inc. | 1,557.87 | $130,394.11 | $102,641.35 | - | -$27,752.76 | -21.28% | -1.854% |
TVTX Travere Therapeutics Inc. | 2,165.66 | $111,176.8 | $108,690.56 | - | -$2,486.24 | -2.24% | -4.928% |